"Designing Growth Strategies is in our DNA"

Multiple Sclerosis Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Immunomodulators, Immunosuppressants, Interferons, and Others), By Route of Administration (Oral and Injection (Intramuscular, Subcutaneous, and Intravenous) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2021-2028

The global multiple sclerosis drugs market size was USD 26.05 billion in 2020. The global impact of the COVID-19 has been unprecedented and staggering, with multiple scle... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Jun, 2021 | Report ID: FBI100386 | Status : Published

 

Speak to Analyst

Refresh Button
Multiple Sclerosis Drugs Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2020
  • 2017-2019
  • 160
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X